Because protein stability is regulated mainly by the ubiquitin–proteasome system and the autophagy system, we treated NLRP12-overexpression gastric cancer cells with MG132, a classical ubiquitination inhibitor, and CQ, an autophagy-lysosomal pathway inhibitor. This evidence concerns the gene NLRP12 and gastric cancer.